Cargando…
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early-onset and/or bilateral Russian breas...
Autores principales: | Krylova, Nadezhda Yu, Lobeiko, Oksana S, Sokolenko, Anna P, Iyevleva, Aglaya G, Rozanov, Maxim E, Mitiushkina, Natalia V, Gergova, Madina M, Porhanova, Tatiana V, Urmancheyeva, Adel F, Maximov, Sergey Ya, Togo, Alexandr V, Imyanitov, Evgeny N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837308/ https://www.ncbi.nlm.nih.gov/pubmed/20223023 http://dx.doi.org/10.1186/1897-4287-4-4-193 |
Ejemplares similares
-
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
por: Suspitsin, Evgeny N, et al.
Publicado: (2009) -
CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007) -
PALB2 mutations in German and Russian patients with bilateral breast cancer
por: Bogdanova, Natalia, et al.
Publicado: (2010) -
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia
por: Plakhins, Grigorijs, et al.
Publicado: (2011) -
Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)